Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington; Surgical Outcomes Research Center, University of Washington, Seattle, Washington.
Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington.
Ann Thorac Surg. 2014 Jul;98(1):175-81; discussion 182. doi: 10.1016/j.athoracsur.2014.03.014. Epub 2014 May 1.
A regional quality improvement effort does not exist for thoracic surgery in the United States. To initiate the development of one, we sought to describe temporal trends and hospital-level variability in associated outcomes and costs of pulmonary resection in Washington (WA) State.
A cohort study (2000-2011) was conducted of operated-on lung cancer patients. The WA State discharge database was used to describe outcomes and costs for operations performed at all nonfederal hospitals within the state.
Over 12 years, 8,457 lung cancer patients underwent pulmonary resection across 49 hospitals. Inpatient deaths decreased over time (adjusted p-trend=0.023) but prolonged length of stay did not (adjusted p-trend=0.880). Inflation-adjusted hospital costs increased over time (adjusted p-trend<0.001). Among 24 hospitals performing at least 1 resection per year, 5 hospitals were statistical outliers in rates of death (4 lower and 1 higher than the state average), and 13 were outliers with respect to prolonged length of stay (7 higher and 6 lower than the state average) and costs (5 higher and 8 lower than the state average). When evaluated for rates of death and costs, there were hospitals with fewer deaths/lower costs, fewer deaths/higher costs, more deaths/lower costs, and more deaths/higher costs.
Variability in outcomes and costs over time and across hospitals suggest opportunities to improve the quality and value of thoracic surgery in WA State. Examples from cardiac surgery suggest that a regional quality improvement collaborative is an effective way to meaningfully and rapidly act upon these opportunities.
在美国,胸外科没有区域性的质量改进工作。为了开展这一工作,我们试图描述华盛顿州肺切除术相关结局和成本的时间趋势和医院间差异。
对接受手术治疗的肺癌患者进行了队列研究(2000-2011 年)。使用华盛顿州出院数据库描述了该州所有非联邦医院的手术结果和成本。
12 年来,49 家医院共对 8457 例肺癌患者进行了肺切除术。住院死亡率随时间降低(调整后趋势检验 p<0.023),但住院时间未延长(调整后趋势检验 p=0.880)。调整通货膨胀后,医院成本随时间增加(调整后趋势检验 p<0.001)。在 24 家每年至少进行 1 次肺切除术的医院中,有 5 家医院的死亡率呈统计学离群(4 家低于州平均水平,1 家高于州平均水平),13 家医院的住院时间延长呈离群(7 家高于州平均水平,6 家低于州平均水平),且成本也呈离群(5 家高于州平均水平,8 家低于州平均水平)。评估死亡率和成本时,有一些医院的死亡率较低/成本较低,一些医院死亡率较低/成本较高,一些医院死亡率较高/成本较低,还有一些医院死亡率较高/成本较高。
随着时间的推移和医院间的差异,结局和成本的变化表明有机会提高华盛顿州胸外科的质量和价值。心脏手术的实例表明,区域质量改进合作是有效利用这些机会的一种方式。